361 related articles for article (PubMed ID: 28636142)
1. Clinical development of immunotherapy for prostate cancer.
Noguchi M; Koga N; Igawa T; Itoh K
Int J Urol; 2017 Sep; 24(9):675-680. PubMed ID: 28636142
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?
Laccetti AL; Subudhi SK
Curr Opin Urol; 2017 Nov; 27(6):566-571. PubMed ID: 28825923
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for prostate cancer: False promises or true hope?
Rekoske BT; McNeel DG
Cancer; 2016 Dec; 122(23):3598-3607. PubMed ID: 27649312
[TBL] [Abstract][Full Text] [Related]
4. Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors.
Grosser R; Cherkassky L; Chintala N; Adusumilli PS
Cancer Cell; 2019 Nov; 36(5):471-482. PubMed ID: 31715131
[TBL] [Abstract][Full Text] [Related]
5. Immune resilience in response to cancer therapy.
Gicobi JK; Barham W; Dong H
Cancer Immunol Immunother; 2020 Nov; 69(11):2165-2167. PubMed ID: 33011909
[No Abstract] [Full Text] [Related]
6. Therapeutic vaccines and immunotherapy in castration-resistant prostate cancer: current progress and clinical applications.
Gulley JL; Madan RA; Heery CR
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714490
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance and new therapies in colorectal cancer.
Van der Jeught K; Xu HC; Li YJ; Lu XB; Ji G
World J Gastroenterol; 2018 Sep; 24(34):3834-3848. PubMed ID: 30228778
[TBL] [Abstract][Full Text] [Related]
8. Advances in cancer vaccines for immunotherapy of prostate cancer.
Jin T; Zhou C; Zhao L; Dong X; Zhou F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):148-156. PubMed ID: 36935188
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for Prostate Cancer: Where We Are Headed.
Schepisi G; Farolfi A; Conteduca V; Martignano F; De Lisi D; Ravaglia G; Rossi L; Menna C; Bellia SR; Barone D; Gunelli R; De Giorgi U
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206214
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy.
Rigamonti N; Bellone M
Cancer Immunol Immunother; 2012 Apr; 61(4):453-68. PubMed ID: 22331081
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of mismatch repair deficiency in prostate cancer.
Sedhom R; Antonarakis ES
Future Oncol; 2019 Jul; 15(20):2395-2411. PubMed ID: 31237441
[TBL] [Abstract][Full Text] [Related]
12. Is There a Role for Immunotherapy in Prostate Cancer?
Rizzo A; Mollica V; Cimadamore A; Santoni M; Scarpelli M; Giunchi F; Cheng L; Lopez-Beltran A; Fiorentino M; Montironi R; Massari F
Cells; 2020 Sep; 9(9):. PubMed ID: 32911806
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.
Gulley JL; Drake CG
Clin Cancer Res; 2011 Jun; 17(12):3884-91. PubMed ID: 21680544
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
Surolia I; Gulley J; Madan RA
Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
[TBL] [Abstract][Full Text] [Related]
15. Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients.
Cabel L; Loir E; Gravis G; Lavaud P; Massard C; Albiges L; Baciarello G; Loriot Y; Fizazi K
J Immunother Cancer; 2017; 5():31. PubMed ID: 28428880
[TBL] [Abstract][Full Text] [Related]
16. Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies.
Madan RA; Gulley JL; Kantoff PW
Cancer J; 2013; 19(1):50-8. PubMed ID: 23337757
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of Prostate Cancer: Facts and Hopes.
Bilusic M; Madan RA; Gulley JL
Clin Cancer Res; 2017 Nov; 23(22):6764-6770. PubMed ID: 28663235
[TBL] [Abstract][Full Text] [Related]
18. Cancer vaccines: current directions and perspectives in prostate cancer.
Mohebtash M; Gulley JL; Madan RA; Ferrara T; Arlen PM
Curr Opin Mol Ther; 2009 Feb; 11(1):31-6. PubMed ID: 19169957
[TBL] [Abstract][Full Text] [Related]
19. The new aspects of immunotherapy in prostate cancer.
Ghanei M; Shohrati M; Saburi A
Cancer Immunol Immunother; 2012 Dec; 61(12):2375-6. PubMed ID: 22736256
[No Abstract] [Full Text] [Related]
20. Trends and advances in tumor immunology and lung cancer immunotherapy.
Aldarouish M; Wang C
J Exp Clin Cancer Res; 2016 Sep; 35(1):157. PubMed ID: 27686848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
